Trevi TherapeuticsTRVI
那斯達克 · USD
7.61
-0.39
(-4.88%)
盤中 08/28 10:43 (UTC+8)
08/28 10:43 (UTC+8)
Trevi TherapeuticsTRVI
7.61
-0.39
(-4.88%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 0 | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | - | - | - | - | - |
營業費用 | 13,722 | 11,470 | 12,243 | 14,086 | 13,289 | - | 8,933 | 9,045 | 8,382 | 7,563 |
研發費用 | 9,389 | 7,811 | 9,328 | 11,224 | 10,021 | 8,804 | 6,518 | 6,323 | 5,842 | 5,000 |
推銷及管理費用 | 4,333 | 3,659 | 2,915 | 2,862 | 3,268 | 3,102 | 2,415 | 2,722 | 2,540 | 2,563 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -13,722 | -11,470 | -12,243 | -14,086 | -13,289 | -11,906 | -8,933 | -9,045 | -8,382 | -7,563 |
其他收入及費用 | - | 1,119 | 845 | 815 | 930 | 997 | 1,134 | 1,337 | 1,360 | 1,386 |
利息費用 | 0 | - | 1 | 1 | 1 | 1 | 4 | 3 | 153 | 231 |
稅前純益 | -12,322 | -10,351 | -11,399 | -13,272 | -12,360 | -10,910 | -7,803 | -7,711 | -7,175 | -6,408 |
所得稅 | -21 | -11 | 16 | -30 | -8 | -8 | 18 | -13 | -30 | -7 |
稅後純益 | -12,301 | -10,340 | -11,415 | -13,242 | -12,352 | -10,902 | -7,821 | -7,698 | -7,145 | -6,401 |
基本每股稅後盈餘(元) | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | - | -0.08 | -0.07 | -0.06 |
稀釋每股稅後盈餘(元) | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | -0.08 | -0.07 | -0.08 | -0.06 |
基本平均股數(千股) | 130350.00 | 117610.00 | 106009.00 | 101282.00 | 101041.00 | 99517.00 | - | 99325.00 | 98698.00 | 98610.00 |
稀釋平均股數(千股) | 130350.00 | 117610.00 | 106009.00 | 101282.00 | 101041.00 | 99517.00 | - | 99325.00 | 98698.00 | 98610.00 |
還原基本每股稅後盈餘(元) | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | - | -0.08 | -0.07 | -0.06 |
還原稀釋每股稅後盈餘(元) | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | -0.08 | -0.07 | -0.08 | -0.06 |
還原基本平均股數(千股) | 130,350 | 117,610 | 106,009 | 101,282 | 101,041 | 99,517 | - | 99,325 | 98,698 | 98,610 |
還原稀釋平均股數(千股) | 130,350 | 117,610 | 106,009 | 101,282 | 101,041 | 99,517 | - | 99,325 | 98,698 | 98,610 |
EBITDA(千元) | -12,284 | -10,709 | -11,657 | -13,588 | -12,657 | -11,255 | -8,115 | -8,145 | -7,520 | -6,748 |